Real-time enrollment status for this recurrent glioblastoma multiforme clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:10 PM UTC
| NCT Number | NCT03423628 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Glioblastoma Multiforme |
| Phase | Clinical Trial |
| Target Enrollment | 180 participants |
| Active Locations | 5 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of July 13, 2026: Clinical trial NCT03423628 is currently recruiting participants. This clinical trial study for recurrent glioblastoma multiforme is actively seeking new participants at 5 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03423628 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03423628 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.